Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

• Status: Completed
• Trial end date: 2006-06-29
• Target enrollment: 0
• Participant gender: All

Summary

The Protocol section needs to be updated using the following text "The main goal of the study was to validate the Preference Module of the EARNS-Q and to test the reliability using Treatment Satisfaction Questionnaire for Medicines (TSQM), a validated questionnaire for determining satisfaction among different treatment. The EARNS-Q is divided into 2 modules, an Experience Module and a Preference Module. The Experience Module includes 28 items, fourteen attribute rating items followed by fourteen importance weighing questions. The Preference Module includes the same items along with preference questions related to each item as well as a global preference question.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Beclomethasone; Flunisolide

Criteria

Inclusion criteria:

• Seasonal allergic rhinitis.

• Nasal allergy symptoms during the spring allergy season.

Exclusion Criteria:

• Prior use of beclomethasone dipropionate or flunisolide.

• Significant concomitant medical conditions.

• Use of corticosteroids.

• Use of allergy and other identified medications during the study.

• Current tobacco use or tobacco use within the past year.